First-line bevacizumab, cisplatin and vinorelbine plus maintenance bevacizumab in advanced non-squamous non-small cell lung cancer chemo-naïve patients
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
First-line bevacizumab, cisplatin and vinorelbine plus maintenance bevacizumab in advanced non-squamous non-small cell lung cancer chemo-naïve patients
Authors
Keywords
-
Journal
EXPERT OPINION ON PHARMACOTHERAPY
Volume 13, Issue 10, Pages 1389-1396
Publisher
Informa Healthcare
Online
2012-05-25
DOI
10.1517/14656566.2012.693165
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Evaluation of Angiogenesis Using Micro-Computed Tomography in a Xenograft Mouse Model of Lung Cancer
- (2015) Rajkumar Savai et al. NEOPLASIA
- Targeting VEGF in lung cancer
- (2012) Millie Das et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Overall survival with cisplatin-gemcitabine and bevacizumab or placebo as first-line therapy for nonsquamous non-small-cell lung cancer: results from a randomised phase III trial (AVAiL)
- (2010) M. Reck et al. ANNALS OF ONCOLOGY
- The Emerging Role of Biomarkers in Advanced Non–Small-Cell Lung Cancer
- (2010) Mark A. Socinski Clinical Lung Cancer
- Maintenance Therapy in Advanced Non-small Cell Lung Cancer
- (2010) Linda E. Coate et al. Journal of Thoracic Oncology
- Gefitinib or Chemotherapy for Non–Small-Cell Lung Cancer with Mutated EGFR
- (2010) Makoto Maemondo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Histology Matters: Individualizing Treatment in Non-Small Cell Lung Cancer
- (2010) J. W. Neal ONCOLOGIST
- A Comparison of Phase II Study Strategies
- (2009) S. Hunsberger et al. CLINICAL CANCER RESEARCH
- Epidermal Growth Factor Receptor Inhibitors and Antiangiogenic Agents for the Treatment of Non-Small Cell Lung Cancer
- (2009) L. Horn et al. CLINICAL CANCER RESEARCH
- Beyond Doublet Chemotherapy for Advanced Non–Small-Cell Lung Cancer: Combination of Targeted Agents with First-Line Chemotherapy
- (2009) Roy S. Herbst et al. Clinical Lung Cancer
- Phase II Study of Pemetrexed and Carboplatin Plus Bevacizumab With Maintenance Pemetrexed and Bevacizumab As First-Line Therapy for Nonsquamous Non–Small-Cell Lung Cancer
- (2009) Jyoti D. Patel et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Trial of Cisplatin Plus Gemcitabine With Either Placebo or Bevacizumab As First-Line Therapy for Nonsquamous Non–Small-Cell Lung Cancer: AVAiL
- (2009) Martin Reck et al. JOURNAL OF CLINICAL ONCOLOGY
- Screening for Epidermal Growth Factor Receptor Mutations in Lung Cancer
- (2009) Rafael Rosell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
- (2009) Tony S. Mok et al. NEW ENGLAND JOURNAL OF MEDICINE
- VEGF as a Marker for Outcome Among Advanced Breast Cancer Patients Receiving anti-VEGF Therapy with Bevacizumab and Vinorelbine Chemotherapy
- (2008) H. J. Burstein et al. CLINICAL CANCER RESEARCH
- Chemotherapy in Addition to Supportive Care Improves Survival in Advanced Non–Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis of Individual Patient Data From 16 Randomized Controlled Trials
- (2008) JOURNAL OF CLINICAL ONCOLOGY
- Efficacy and side effects of cisplatin- and carboplatin-based doublet chemotherapeutic regimens versus non-platinum-based doublet chemotherapeutic regimens as first line treatment of metastatic non-small cell lung carcinoma: A systematic review of randomized controlled trials
- (2007) Anand Rajeswaran et al. LUNG CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now